Susan E. Creary

1.2k total citations · 1 hit paper
67 papers, 745 citations indexed

About

Susan E. Creary is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Susan E. Creary has authored 67 papers receiving a total of 745 indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Genetics, 43 papers in Hematology and 20 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Susan E. Creary's work include Hemoglobinopathies and Related Disorders (57 papers), Iron Metabolism and Disorders (36 papers) and Prenatal Screening and Diagnostics (15 papers). Susan E. Creary is often cited by papers focused on Hemoglobinopathies and Related Disorders (57 papers), Iron Metabolism and Disorders (36 papers) and Prenatal Screening and Diagnostics (15 papers). Susan E. Creary collaborates with scholars based in United States, Canada and Jamaica. Susan E. Creary's co-authors include Sarah H. O’Brien, Joseph Stanek, Lakshmanan Krishnamurti, John J. Strouse, Jeffrey Glassberg, Eddy Lang, Robert W. Hurley, William T. Zempsky, Mohamed O. Seisa and Amanda M. Brandow and has published in prestigious journals such as Blood, PLoS ONE and American Psychologist.

In The Last Decade

Susan E. Creary

61 papers receiving 729 citations

Hit Papers

American Society of Hematology 2020 guidelines for sickle... 2020 2026 2022 2024 2020 50 100 150 200

Peers

Susan E. Creary
Yih‐Ming Yang United States
Kerry Morrone United States
Joylene John‐Sowah United States
Debra Pollard United Kingdom
Allison Streetly United Kingdom
Araba Afenyi‐Annan United States
Jeffrey D. Hord United States
Jennifer Welch United States
Philippa G. Sprinz United States
Susan E. Creary
Citations per year, relative to Susan E. Creary Susan E. Creary (= 1×) peers Jeffrey D. Lebensburger

Countries citing papers authored by Susan E. Creary

Since Specialization
Citations

This map shows the geographic impact of Susan E. Creary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan E. Creary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan E. Creary more than expected).

Fields of papers citing papers by Susan E. Creary

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan E. Creary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan E. Creary. The network helps show where Susan E. Creary may publish in the future.

Co-authorship network of co-authors of Susan E. Creary

This figure shows the co-authorship network connecting the top 25 collaborators of Susan E. Creary. A scholar is included among the top collaborators of Susan E. Creary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan E. Creary. Susan E. Creary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Creary, Susan E., et al.. (2024). Experiences and outcomes of fertility testing in male adolescents with sickle cell disease. Pediatric Blood & Cancer. 71(4). e30848–e30848. 2 indexed citations
4.
O’Brien, Sarah H., Joseph Stanek, Andrew A. House, et al.. (2024). Trends in Pregnancy Outcomes in People with Sickle Cell Disease and Medicaid Insurance (2006–2018). Journal of Women s Health. 34(1). 21–26. 2 indexed citations
5.
Walden, Joseph, et al.. (2024). Influenza vaccine uptake among youth with sickle cell disease who are seen in clinic before and after the COVID-19 pandemic. Vaccine. 42(22). 126212–126212. 1 indexed citations
6.
Abrams, Mary Ann, et al.. (2023). Closing knowledge gaps among parents of children with sickle cell trait. Pediatric Blood & Cancer. 70(7). e30384–e30384. 2 indexed citations
7.
Nahata, Leena, Gwendolyn P. Quinn, John J. Strouse, & Susan E. Creary. (2023). Addressing fertility in adolescent boys with sickle cell disease: emerging clinical and ethical dilemmas. Blood Advances. 7(18). 5351–5353. 2 indexed citations
8.
Agarwal, Shreya, Joseph Stanek, Sara K. Vesely, et al.. (2023). Pregnancy‐related thromboembolism in women with sickle cell disease: An analysis of National Medicaid Data. American Journal of Hematology. 98(11). 1677–1684. 11 indexed citations
9.
Abrams, Mary Ann, Joseph Stanek, Sarah H. O’Brien, et al.. (2022). Acceptability to and Engagement With a Virtual Sickle Cell Trait Education Program (SCTaware): Single-Center Prospective Study. JMIR Formative Research. 6(11). e38780–e38780. 2 indexed citations
10.
Creary, Susan E., Joseph Stanek, Kathryn King, et al.. (2022). Impact of hydroxyurea dose and adherence on hematologic outcomes for children with sickle cell anemia. Pediatric Blood & Cancer. 69(6). e29607–e29607. 8 indexed citations
11.
Abrams, Mary Ann, et al.. (2021). Closing Knowledge Gaps Among Parents of Children with Sickle Cell Trait. Blood. 138(Supplement 1). 2980–2980. 1 indexed citations
12.
Dombkowski, Kevin J., et al.. (2021). Influenza immunization coverage of children with sickle cell disease. Vaccine. 39(39). 5538–5540. 4 indexed citations
13.
Dombkowski, Kevin J., et al.. (2021). Primary Immunization Series Coverage of Children With Sickle Cell Disease. American Journal of Preventive Medicine. 61(1). 124–127. 1 indexed citations
14.
Niss, Omar, Adam Lane, Monika Asnani, et al.. (2020). Progression of albuminuria in patients with sickle cell anemia: a multicenter, longitudinal study. Blood Advances. 4(7). 1501–1511. 33 indexed citations
15.
Brandow, Amanda M., C. Patrick Carroll, Susan E. Creary, et al.. (2020). American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain. Blood Advances. 4(12). 2656–2701. 216 indexed citations breakdown →
16.
Meier, Emily Riehm, Susan E. Creary, Matthew M. Heeney, et al.. (2020). Hydroxyurea Optimization through Precision Study (HOPS): study protocol for a randomized, multicenter trial in children with sickle cell anemia. Trials. 21(1). 983–983. 11 indexed citations
17.
Creary, Susan E., Deena J. Chisolm, & Sarah H. O’Brien. (2016). ENHANCE—(Electronic Hydroxyurea Adherence): A Protocol to Increase Hydroxyurea Adherence in Patients with Sickle Cell Disease. JMIR Research Protocols. 5(4). e193–e193. 12 indexed citations
18.
Kumar, Riten, Susan E. Creary, Liz Varga, & Samir B. Kahwash. (2016). Thrombocytopenia Pitfalls: Misdiagnosing Type 2B von Willebrand Disease as Ethylenediaminetetraacetic Acid−Dependent Pseudothrombocytopenia. The Journal of Pediatrics. 175. 238–238.e1. 3 indexed citations
19.
Creary, Susan E., Susan Zickmund, Diana Ross, Lakshmanan Krishnamurti, & Debra L. Bogen. (2015). Hydroxyurea therapy for children with sickle cell disease: describing how caregivers make this decision. BMC Research Notes. 8(1). 372–372. 16 indexed citations
20.
Creary, Susan E., Mark E. Heiny, James M. Croop, et al.. (2011). Clinical course of postthrombotic syndrome in children with history of venous thromboembolism. Blood Coagulation & Fibrinolysis. 23(1). 39–44. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026